My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AbbVie (NY:ABBV)

214.35 -0.67 (-0.31%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

92 93 Next >

Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

June 18, 2024

Via Benzinga

Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' ↗

June 17, 2024

On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named ConocoPhillips, and Rob Sechan suggested AbbVie, with all four stocks having...

Via Benzinga

2 Dividend Stocks That Could Pay You for Life ↗

June 16, 2024

There are other reasons to love these businesses, too.

Via The Motley Fool

7 A-Rated Biotech Stocks Worth Betting on in June ↗

June 14, 2024

A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.

Via InvestorPlace

The Dividend Defenders: 3 Stocks That Will Protect and Grow Your Wealth Dividend Stocks ↗

June 14, 2024

Are you looking for some defenders for your portfolio? Here are three dividend stocks to protect and grow your wealth.

Via InvestorPlace

Looking Into AbbVie's Recent Short Interest ↗

June 13, 2024

Via Benzinga

Comparative Study: AbbVie And Industry Competitors In Biotechnology Industry ↗

June 11, 2024

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,100 Today ↗

June 10, 2024

Via Benzinga

Blue-Chip Bonanzas: 3 Industry Leaders Trading at Unbelievable Discounts ↗

June 12, 2024

Thanks to the predictability of big businesses, the bargains found among undervalued blue-chip stocks are simply more trustworthy.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 11, 2024

Via Benzinga

Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside ↗

June 07, 2024

Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 07, 2024

Via Benzinga

AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability ↗

June 07, 2024

Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance...

Via Benzinga

Analyst Scoreboard: 6 Ratings For AbbVie ↗

June 05, 2024

Via Benzinga

AbbVie's Options Frenzy: What You Need to Know ↗

June 03, 2024

Via Benzinga

AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades' ↗

June 07, 2024

AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners.

Via Benzinga

AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated Ovarian Cancer Patients ↗

June 06, 2024

AbbVie announced Phase 2 PICCOLO trial results for Elahere in heavily pre-treated ovarian cancer patients. The trial achieved a 51.9% objective response rate.

Via Benzinga

Investing in Biotech: High Risk for a Potentially High Reward

June 06, 2024

Biotech is an exciting and promising area, and investors with some patience, the stomach for volatility, and a high risk tolerance can potentially benefit.

Via MarketBeat

7 Stocks That Could Safely 10X by 2030 ↗

June 06, 2024

Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

Via InvestorPlace

Hedge Fund Favorites: 7 Stocks to Buy When You’re Feeling Jittery ↗

June 06, 2024

With the hedge funds targeting certain ideas with their vast resources, retail investors can ride coattails with these stocks to buy.

Via InvestorPlace

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential ↗

June 05, 2024

If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off.

Via InvestorPlace

2 High-Yield Dividend Stocks to Buy Right Now ↗

June 05, 2024

These two high-yield dividend stocks are top buys right now.

Via The Motley Fool

The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme ↗

June 05, 2024

Top dividend stocks across various sectors continue to reward investors, even as they face sales shortfalls and leadership changes.

Via InvestorPlace

Top Stocks to Buy in June ↗

June 04, 2024

Here are a few high-quality stocks trading at intriguing valuations.

Via The Motley Fool

TJX, Sysco, Lululemon And A Healthcare Stock On CNBC's 'Final Trades' ↗

June 03, 2024

Brenda Vingiello of Sand Hill Global Advisors named TJ Maxx's parent company, The TJX Companies Inc., as her final trade.

Via Benzinga

7 Overlooked Stocks That Belong in Every Portfolio ↗

June 03, 2024

Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks.

Via InvestorPlace

3 No-Brainer Stocks to Buy in June ↗

June 02, 2024

Now is the time to invest in these great stocks.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 31, 2024

Via Benzinga

2 Generic Drug Makers With Growing Runways

May 31, 2024

Brand name drug costs continue to climb but patients and insurers find respite by migrating to generic or biosimilar versions as patents run out.

Via MarketBeat

Topics Intellectual Property

3 Dividend Stocks to Double Up on Right Now ↗

May 30, 2024

The stories for these great dividend stocks are better than many might think.

Via The Motley Fool

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

92 93 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.